Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Many mechanisms have been proposed to explain why immune responses against human tumor antigens are generally ineffective. For example, tumor cells have been shown to develop active immune evasion mechanisms. Another possibility is that tumor antigens are unable to optimally stimulate tumor-specific...

Detaylı Bibliyografya
Asıl Yazarlar:	Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	1999

Benzer Materyaller

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
Yazar:: Valmori, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Yazar:: Valmori, D, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

An antigen-targeted approach to adoptive transfer therapy of cancer.
Yazar:: Valmori, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
Yazar:: Romero, P, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
Yazar:: Valmori, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
Yazar:: Pittet, M, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
Yazar:: Speiser, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
Yazar:: Speiser, D, ve diğerleri
Baskı/Yayın Bilgisi: (1999)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Yazar:: Valmori, D, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Immune monitoring in cancer immunotherapy.
Yazar:: Romero, P, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
Yazar:: Chen, J, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Yazar:: Hudrisier, D, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Tumor cell recognition efficiency by T cells.
Yazar:: Daniel E Speiser, ve diğerleri
Baskı/Yayın Bilgisi: (2005-03-01)

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
Yazar:: Juliette Desfrançois, ve diğerleri
Baskı/Yayın Bilgisi: (2010-01-01)

Quantitating T cell cross-reactivity for unrelated peptide antigens.
Yazar:: Ishizuka, J, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
Yazar:: Douglas McNeel, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Antigen presentation. Naturally processed peptides.
Yazar:: Elliott, T, ve diğerleri
Baskı/Yayın Bilgisi: (1990)

The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
Yazar:: Hudrisier, D, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Antigenic reactivity of peptides derived from wheat gluten with sera from patients with coeliac disease.
Yazar:: Rawcliffe, P, ve diğerleri
Baskı/Yayın Bilgisi: (1985)

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
Yazar:: Youde, S, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
Yazar:: Kessler, B, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
Yazar:: Aleksic, M, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
Yazar:: Danila Valmori, ve diğerleri
Baskı/Yayın Bilgisi: (2004-11-01)

Reactivity of sulfonylbutadienes. Synthesis of Ginsenol analogues
Yazar:: David Diez, ve diğerleri
Baskı/Yayın Bilgisi: (2010-10-01)

A tumor-binding antibody with cross-reactivity to viral antigens
Yazar:: Michael J. Campa, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
Yazar:: Griffiths, E, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
Yazar:: Laura Carretero-Iglesia, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
Yazar:: Larsson, M, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
Yazar:: André, P, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Synthesis and reactivity of novel gamma-phosphate modified ATP analogues.
Yazar:: Lee, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Synthesis and reactivity of novel γ-phosphate modified ATP analogues
Yazar:: Lee, SE, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Synthesis of a novel analogue of peptide ProGlyPro
Yazar:: A. V. Baranov, ve diğerleri
Baskı/Yayın Bilgisi: (2006-12-01)

Identifying individual T cell receptors of optimal avidity for tumor antigens
Yazar:: Michaël eHebeisen, ve diğerleri
Baskı/Yayın Bilgisi: (2015-11-01)

IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES
Yazar:: A. Yu. Artamonov, ve diğerleri
Baskı/Yayın Bilgisi: (2014-07-01)

363 Identification of dark antigen® reactive T cell receptors from tumor-infiltrating lymphocytes
Yazar:: Özcan Met, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Yazar:: Kessler, B, ve diğerleri
Baskı/Yayın Bilgisi: (1998)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
Yazar:: Lahman, MC, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
Yazar:: Wenwen Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
Yazar:: Smith, D, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
Yazar:: Speiser, D, ve diğerleri
Baskı/Yayın Bilgisi: (1997)